ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF LEVOBUNOLOL
The invention relates to a new, industrially advantageous, process for the preparation of the known beta-adrenergic blocking agent levobunolol, not requiring resolution of racemic bunolol, based on the enantioselective synthesis of an oxiranic intermediate which is then reacted with tert-butylamine....
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a new, industrially advantageous, process for the preparation of the known beta-adrenergic blocking agent levobunolol, not requiring resolution of racemic bunolol, based on the enantioselective synthesis of an oxiranic intermediate which is then reacted with tert-butylamine. The process of this invention consists of reacting 5-hydroxy-3,4-dihydro-1(2H)-naphthalenone with (R)-(-)epichlor-hydrine in an aprotic solvent in the presence of a strong base at a temperature of over 90.degree.C, thus obtaining the intermediate chiral oxirane (S)-5-(2,3-epoxypropoxy)-3,4-dihydro-1-(2H) --naphthalenone with more than 95% optical purity, and then, the intermediate chiral oxirane is reacted with tert-butylamine. |
---|